Presentation is loading. Please wait.

Presentation is loading. Please wait.

Transcutaneous aortic valve implantation using the axillary/subclavian access: Feasibility and early clinical outcomes  Thomas Modine, MD, PhD, Jean François.

Published byStewart Blake Modified over 5 years ago

Similar presentations

Presentation on theme: "Transcutaneous aortic valve implantation using the axillary/subclavian access: Feasibility and early clinical outcomes  Thomas Modine, MD, PhD, Jean François."— Presentation transcript:

1 Transcutaneous aortic valve implantation using the axillary/subclavian access: Feasibility and early clinical outcomes  Thomas Modine, MD, PhD, Jean François Obadia, MD, PhD, Emmanuel Choukroun, MD, PhD, Gilles Rioufoul, MD, PhD, Arnaud Sudre, MD, Jean Claude Laborde, MD, PhD, Pascal Leprince, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 141, Issue 2, Pages e1 (February 2011) DOI: /j.jtcvs Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Angiogram sheath views in the subclavian and axillary arteries (A) and ascending aorta (B). The Journal of Thoracic and Cardiovascular Surgery  , e1DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

3 Subclavian surgical access; 18F sheath insertion.
The Journal of Thoracic and Cardiovascular Surgery  , e1DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

4 Surgical access closed.
The Journal of Thoracic and Cardiovascular Surgery  , e1DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Transcutaneous aortic valve implantation using the axillary/subclavian access: Feasibility and early clinical outcomes  Thomas Modine, MD, PhD, Jean François."

Similar presentations

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion

Of mice and men and surgical transcatheter aortic valve insertion
Manuel J. Antunes, MD, PhD, DSc 

Manuel J. Antunes, MD, PhD, DSc 
Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion  Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.

Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion  Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.
Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD 

Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD 
Percutaneous aortic valves: Effective in inoperable patients, what price in high-risk patients?  Lars G. Svensson, MD, PhD  The Journal of Thoracic and.

Percutaneous aortic valves: Effective in inoperable patients, what price in high-risk patients?  Lars G. Svensson, MD, PhD  The Journal of Thoracic and.
Surgery for congenital diseases of the aorta

Surgery for congenital diseases of the aorta
Expanding options to manage traumatic thoracic vascular injuries

Expanding options to manage traumatic thoracic vascular injuries
Pulmonary valve replacement in repaired tetralogy of Fallot by left thoracotomy avoid ascending aorta injury  Roland Henaine, MD, Naoki Yoshimura, MD,

Pulmonary valve replacement in repaired tetralogy of Fallot by left thoracotomy avoid ascending aorta injury  Roland Henaine, MD, Naoki Yoshimura, MD,
Replacement of the ascending aorta in bicuspid aortic valve disease: Where do we draw the line?  Thoralf M. Sundt, MD  The Journal of Thoracic and Cardiovascular.

Replacement of the ascending aorta in bicuspid aortic valve disease: Where do we draw the line?  Thoralf M. Sundt, MD  The Journal of Thoracic and Cardiovascular.
Intrinsic cardiac stem cells are essential for regeneration

Intrinsic cardiac stem cells are essential for regeneration
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 

Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Aortic valve implantation with the CoreValve ReValving System via left carotid artery access: First case report  Thomas Modine, MD, Gilles Lemesle, MD,

Aortic valve implantation with the CoreValve ReValving System via left carotid artery access: First case report  Thomas Modine, MD, Gilles Lemesle, MD,
Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 

Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 
Bicuspid aortic valve aortopathy: One size fits all?

Bicuspid aortic valve aortopathy: One size fits all?
Bigger The Journal of Thoracic and Cardiovascular Surgery

Bigger The Journal of Thoracic and Cardiovascular Surgery
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
The lord of the rings  Antonio Miceli, MD, PhD 

The lord of the rings  Antonio Miceli, MD, PhD 
Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model  Daniel.

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model  Daniel.

Similar presentations

Ads by Google